0001947620-25-000003.txt : 20250805 0001947620-25-000003.hdr.sgml : 20250805 20250805133143 ACCESSION NUMBER: 0001947620-25-000003 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506(b) provides a "safer harbor" for a private offering FILED AS OF DATE: 20250805 DATE AS OF CHANGE: 20250805 EFFECTIVENESS DATE: 20250805 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Lapix Therapeutics Inc. CENTRAL INDEX KEY: 0001947620 ORGANIZATION NAME: EIN: 842410144 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-553733 FILM NUMBER: 251184082 BUSINESS ADDRESS: STREET 1: 75 KNEELAND STREET STREET 2: 14TH FLOOR CITY: BOSTON STATE: MA ZIP: 02111 BUSINESS PHONE: 1 (617) 766-3909 MAIL ADDRESS: STREET 1: 75 KNEELAND STREET STREET 2: 14TH FLOOR CITY: BOSTON STATE: MA ZIP: 02111 D 1 primary_doc.xml X0708 D LIVE 0001947620 Lapix Therapeutics Inc. 271 Cambridge St., 2nd Floor Cambridge MA MASSACHUSETTS 02141 8582264717 DELAWARE None None Corporation true Anas Fathallah c/o Lapix Therapeutics, Inc. 271 Cambridge St., 2nd Floor Cambridge MA MASSACHUSETTS 02141 Executive Officer Director President and Secretary Jason Norris c/o Lapix Therapeutics, Inc. 271 Cambridge St., 2nd Floor Cambridge MA MASSACHUSETTS 02141 Executive Officer Director Vice President and Treasurer Henry McKinnell c/o Lapix Therapeutics, Inc. 271 Cambridge St., 2nd Floor Cambridge MA MASSACHUSETTS 02141 Director Francisco Leon c/o Lapix Therapeutics, Inc. 271 Cambridge St., 2nd Floor Cambridge MA MASSACHUSETTS 02141 Director Anthony Gibney c/o Lapix Therapeutics, Inc. 271 Cambridge St., 2nd Floor Cambridge MA MASSACHUSETTS 02141 Director Other Technology Decline to Disclose 06b false 2025-07-21 false true Simple Agreement for Future Equity false 1000 5000000 2200000 2800000 false 10 0 true 0 true 0 true false Lapix Therapeutics Inc. /s/ Ana Fathallah Anas Fathallah President 2025-08-05